Business of Medicine
Latest News
Why Do So Many Doctors Embrace Superstitions and Rituals?
“Rituals and superstitions are an acknowledgment that forces external to ourselves exist.”
From the Journals
Physicians Received $12 Billion from Drug, Device Makers in Less Than 10 Years
Industry payments appeared to have been little changed by public reporting in the Open Payments database.
Latest News
Time Is Money: Should Physicians Be Compensated for EHR Engagement?
“I think it’s reasonable to consider it being reimbursed because we’re taking our time and effort and making decisions to help the patient.”
Latest News
Understanding and Promoting Compassion in Medicine
Improving compassion may depend on the creation of organizational and clinical conditions in which physician compassion can thrive.
Hitting a Nerve
AI for Email Replies? Not Yet
AI needs to be a lot better before I let it handle patient questions and concerns.
From the Journals
Few Childhood Cancer Survivors Get Recommended Screenings
‘As many as four out of five of these survivors will develop a serious or life-threatening late effect of their cancer therapy by age 45,’ the...
Latest News
AI May Help Docs Reply to Patients’ Portal Messages
A small quality-improvement study found physicians’ burden was lessened but time spent was the same.
From the Journals
Most Cancer Trial Centers Located Closer to White, Affluent Populations
Researchers compare the distributions of patients of different races and socioeconomic statuses to the locations of clinical research facilities...
Feature
Diagnosis Denial: How Doctors Help Patients Accept Their Condition
Physicians need to spend time explaining the diagnosis then help the patient reimagine their future with the diagnosis.
Managing Your Practice
Clock Watchers
Generally, clock watchers — sometimes referred to in modern parlance as “quiet quitters” — radiate a palpable sense of “I don’t want to be here...
Feature
Extraordinary Patients Inspired Father of Cancer Immunotherapy
Renowned researcher, Dr. Steven A. Rosenberg, describes his path to pioneering the use of immunotherapies in treating cancer.